Prognostic factors in Neuroendocrine Lung Tumors: A Spanish Multicenter Study

Annals of Thoracic Surgery

Volumn 70, Issue 1, 2000, Pages 258-263

  García Yuste, Mariano ^a   Matilla, José M ^a   Alvarez Gago, Tomás ^a   Duque, José L ^a   Heras, Félix ^a   Cerezal, Luis J ^a   Ramos, Guillermo ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CHILD; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROENDOCRINE SYSTEM; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SPAIN;

ADULT; AGED; CARCINOID TUMOR; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROGNOSIS; SPAIN; SURVIVAL RATE;

EID: 0343497057     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01369-2     Document Type: Article

References (22)

1. The World Health Organization histological typing of lung tumors. Second edition. Am J Clin Pathol. 77:1982;123-136.
2. Travis W.D., Linnoila R.I., Tsokos M.G., et al. Neuroendocrine tumors of the lung with proposed criteria for large cell neuroendocrine carcinoma. A structural, immunohistochemical and flow citometric study of 35 cases. Am J Surg Pathol. 15:1991;529-553.
3. Dresler C.M., Ritter J.H., Patterson G.A., Ross E., Biley M.S., Wick M.R. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg. 63:1997;180-185.
4. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717.
5. Gosney J.R. Endocrine pathology of the lung. Anthony P.P., McSween R.N.M. Recent advances in histopathology 16. 1994;147-166 Churchill Livingstone, Edinburgh.
6. Addis N.J., Hamid Q., Ibrahi N.B.N., Fahey M., Bloom S.R., Polak J.M. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumors of the lung. J Pathol. 153:1987;137-150.
7. Komminoth P., Roth J., Lakie P.M., Birter-Suermman D., Heitz P.U. Polysialic acid of neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoid. Am J Pathol. 139:1991;297-304.
8. Gould V.E., Linnoila R.J., Menoli V.A., Warren W.H. Neuroendocrine components of the bronchopulmonary tract hyperplasias, dysplasias, and neoplasms. Lab Invest. 49:1983;519-537.
9. Paladugu R.R., Benfield J.R., Pak H.Y., Ross R.K., Teplitz R.L. Bronchopulmonary Kulchitsky cell carcinomas a new classification scheme for typical and atypical carcinoid . Cancer. 55:1985;1303-1311.
10. Lequaglie C., Patriarca C., Cataldo I., Muscolino G., Preda F., Ravasi G. Prognosis of resected well-differentiated neuroendocrine carcinoma of the lung. Chest. 100:1991;1053-1056.
11. Warren H.W., Faber L.P., Gould E.V. Neuroendocrine neoplasms of the lung clinicopathologic update . J Thorac Cardiovasc Surg. 98:1989;321-322.
12. Marty-Ané C.H., Costes V., Pujol J.L., Aluzen M., Baldet P., Mary H. Carcinoid tumors of the lung do atypical features require aggressive management? Ann Thorac Surg. 59:1995;78-83.
13. Okike N., Bernatz P.E., Woolner L.B. Carcinoid tumors of the lung. Ann Thorac Surg. 22:1976;270-277.
14. Chughtai T., Morin J., Sheiner N., Wilson J., Mulder D. Bronchial carcinoid. Twenty years' experience defines a selective surgical approach. Surgery. 122:1997;801-808.
15. Wilkins E.W., Grillo H.C., Moncure A.C., Scannell J.G. Changing times in surgical management of bronchopulmonary carcinoid tumor. Ann Thorac Surg. 38:1984;339-344.
16. Grote T.H., Macon W.R., Davis B., Greco F.A., Johnson D.H. Atypical carcinoid of the lung. A distinct clinicopathologic entity. Chest. 93:1988;370-375.
17. Thunnissen F.B., Van Eijk J., Baak J.P., et al. Bronchopulmonary carcinoids and regional limph node metastases. A quantitative pathologic investigation. Am J Pathol. 132:1988;119-122.
18. Martini N., Zaman M., Bains M., et al. Treatment and prognosis in bronchial carcinoid involving regional lymph nodes. J Thorac Cardiovasc Surg. 107:1994;1-7.
19. Graziano S.L., Tarum A.H., Newman N.B., et al. The prognostic significance of neuroendocrine markers of carcinoembryonic antigen on patients with resected stage I and II non-small cell cancer. Cancer Res. 54:1994;2908-2913.
20. Linnoila R.I., Piantadosi S., Ruckdeschel J.C. Impact of neuroendocrine differentiation and clinical behavior in non-small cell lung cancer the LCSG experience . Chest. 106:1994;367S-371S.
21. Schleusener J.T., Tazelaar H.D., Jung S., et al. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy treated non-small cell carcinoma. Cancer. 77:1996;1284-1291.
22. Carles J., Rosell R., Ariza A., et al. Neuroendocrine differentiation as a prognosis factor in non-small cell lung cancer. Lung Cancer. 10:1993;209-219.